FDA Inspection 1228827 — Novartis d.o.o.
The FDA completed an inspection of Novartis d.o.o. on September 21, 2022 in Menges. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 21, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Menges (Slovenia)
Additional Details
Mutual Recognition Agreement (MRA)